TABLE 3.
Anti-N-IgG | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Months | SOTRs |
Controls |
n diff | G-mean ratio | Lower 95% CL for ratio | Upper 95% CL for ratio | p | ||||
n | G-mean | CV (%) | n | G-mean | CV (%) | ||||||
1 | 22 | 1.77 | 748.5 | 23 | 4.05 | 144.2 | 12 | 0.16 | 0.04 | 0.54 | .007 |
3 | 42 | 0.98 | 568.2 | 55 | 3.80 | 104.6 | 40 | 0.27 | 0.15 | 0.51 | .0001 |
6 | 41 | 0.54 | 433.4 | 29 | 1.55 | 187.9 | 23 | 0.30 | 0.11 | 0.80 | .019 |
9 | 20 | 0.39 | 359.6 | 41 | 1.06 | 184.3 | 18 | 0.31 | 0.11 | 0.82 | .021 |
Anti-S-IgG | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Months | SOTRs |
Controls |
n diff | G-mean ratio | Lower 95% CL for ratio | Upper 95% CL for ratio | p | ||||
n | G-mean | CV (%) | n | G-mean | CV (%) | ||||||
1 | 22 | 164.7 | 1151.6 | 21 | 158.1 | 331.6 | 11 | 0.51 | 0.04 | 6.65 | .570 |
3 | 46 | 71.7 | 5705.8 | 55 | 169.2 | 218.0 | 42 | 0.42 | 0.17 | 1.02 | .055 |
6 | 45 | 78.9 | 1642.5 | 27 | 67.8 | 189.3 | 21 | 0.61 | 0.19 | 1.99 | .393 |
9 | 28 | 46.9 | 5543.3 | 41 | 74.0 | 269.4 | 24 | 0.71 | 0.16 | 3.25 | .650 |
Note: Comparison between groups at each time point by applying a t-test to the differences of log-transformed data within each matched pair. The analysis only uses serological data points that have a corresponding data point available in the matched control.
Values in bold are considered statistically significant with a p value <.05.